Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2879-20-1 | MDL No. : | MFCD00006823 |
Formula : | C10H10O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HGVWMTAIIYNQSI-UHFFFAOYSA-N |
M.W : | 178.18 | Pubchem ID : | 76143 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.3 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 47.51 |
TPSA : | 35.53 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.0 cm/s |
Log Po/w (iLOGP) : | 2.08 |
Log Po/w (XLOGP3) : | 0.54 |
Log Po/w (WLOGP) : | 1.66 |
Log Po/w (MLOGP) : | 0.74 |
Log Po/w (SILICOS-IT) : | 2.45 |
Consensus Log Po/w : | 1.49 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.56 |
Solubility : | 4.9 mg/ml ; 0.0275 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.86 |
Solubility : | 24.7 mg/ml ; 0.139 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.76 |
Solubility : | 0.308 mg/ml ; 0.00173 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.06 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With Dess-Martin periodane In dichloromethane at 0 - 20℃; for 16 h; Inert atmosphere | General procedure: Method B: to a solution of compound 4a (1.65 g, 9.94 mmol) inanhydrous CH2Cl2 (100 mL) stirred at 0 C under argon was addedDess-Martin reagent (5.06 g,11.93 mmol). The mixture was allowedto warm to room temperature after 10 min and stirred for 16 h. Thereaction was quenched with a saturated sodium bicarbonate solution and salts were filtered off. The filtrate was extracted withCH2Cl2. The combined organic layers were dried over MgSO4,filtered and evaporated under reduced pressure. Purification bysilica column chromatography using CH2Cl2 as eluent gave thedesired ketone 5a (1.42 g, 87percent) as a pale yellow solid. |
[ 20632-12-6 ]
1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)propan-1-one
Similarity: 0.98
[ 6100-74-9 ]
3'-Hydroxy-4'-methoxyacetophenone
Similarity: 0.96
[ 1131-62-0 ]
1-(3,4-Dimethoxyphenyl)ethanone
Similarity: 0.96
[ 23428-77-5 ]
1-(3-(Benzyloxy)-4-methoxyphenyl)ethanone
Similarity: 0.94
[ 1835-04-7 ]
1-(3,4-Dimethoxyphenyl)propan-1-one
Similarity: 0.93
[ 20632-12-6 ]
1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)propan-1-one
Similarity: 0.98
[ 29668-44-8 ]
2,3-Dihydrobenzo[b][1,4]dioxine-6-carbaldehyde
Similarity: 0.91
[ 4442-54-0 ]
2,3-Dihydro-1,4-benzodioxine-6-carboxylic acid
Similarity: 0.80
[ 4442-53-9 ]
2,3-Dihydrobenzo[b][1,4]dioxine-5-carboxylic acid
Similarity: 0.74
[ 39270-39-8 ]
(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)methanol
Similarity: 0.72